Mann S, Droz P, Vahter M. A Physidogically bnsed pharmacokinetic model for Arsenic exposure Ⅱ. Validation and application in humans[J]. Toxicol Appl Pharmacol, 1996, 140:471.
De Kimpe J, Comelis R, Mees L, et al. Basal metabolism of intraperitoneally injected carrier-free^74 As-labeled arsenate in rabbits Fund Appl Toxicol, 1996,34:240.
Cui X, Kobayashi Y, Hayakawa T, et al. Arsenic speciation in bile and urine following oral and intravenous exposure to inorganic and organic arsenics in rats[J]. Toxicol Sci, 2004,82(2) :478.
Goering P L, Aposhian H V, Mass M J, et al. The enigma of arsenic carcinogenesis : rolemetabolism [J]. Toxicol Sci, 1999,49 (1) :5.
[21]
袁倬斌 韩树波.含砷矿物药在体内存在形态的研究方法[J].药学学报,:.
[22]
程增江 田鹤 等.口服雄黄对大鼠脏器中铜、锌、硒含量的影响[J].中国中药杂志,:.
[23]
Yamauchi H, Kinoshita J, Nagai N, et al. Study on metabolism of arsenic in the patients with acute arsenic poisoning by intake of arsenic tfi-oxide in Wakayama City. Japan : San Diego [C]. CA, 2000:24.
